Browsing HLS Student Papers by Title
Now showing items 267-286 of 498
-
The Liability of Drug Analysis from the Story of Intravenous Iodine-Contained Contrast Medium
(1999)The development of the liability of drugs is a complicated and sophisticated process, like the development of drugs. Intravenous iodine-contained contrast medium, a diagnostic drug with excellent effectiveness and unavoidable ... -
The Life of the Abortion Pill in the United States
(2000)During the last eleven years, the efforts of those fighting to make mifepristone available in the United States have been thwarted by those fighting just as valiantly to keep it out. The struggle between the two groups is ... -
Lifting the Fog: The Problem of Antipsychotic Drug Use in Nursing Facilities
(2011)With the rapid increase in the elder population nationwide, the problem of excessive dependence on risky antipsychotic drug treatment for dementia-related behavioral problems in nursing facilities must be addressed. At ... -
Litigating the Drug Price Competition and Patent Term Restoration Act of 1984
(2000)The Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman Act in honor of its sponsors Senator Orrin Hatch and Representative Henry Waxman, was enacted in an attempt to reconcile ... -
Loco for Four Loko: Regulating Caffeinated Alcoholic Beverages
(2011)Young people across the nation have been going loco for Four Loko, a caffeinated alcoholic beverage (CAB) that some college students have dubbed “blackout in a can.” Just a few months ago, the Food and Drug Administration ... -
A Look at The Drug Price Competition and Patent Term Restoration Act of 1984
(2002)The DPC-PTR Act was a piece of legislation that was fought over bitterly by the generic and research-based industries, and passed only when a tenuous balance was reached through last-minute negotiations. "One indication ... -
Making Sense of Commercial Speech: A Theoretical Framework and A Case Study in Food and Drug Law
(2005)This Note creates a theoretical framework for understanding commercial speech as a form of hybrid expression. It describes how commercial speech shares some features with expressive conduct and other characteristics with ... -
The Mammography Quality Standards Act: Misread Mammograms, Malpractice, and The Politics of Regulation
(2003)Recent studies and reports suggest that the MQSA has not been successful at improving physician interpretation of mammograms. This paper argues that in order to assess the impact of the MQSA accurately, one must look beyond ... -
Managed Care and the Pharmaceutical Industry
(1995)The 1992 presidential campaign turned the nation's attention to a number of issues. but none was more controversial than the need for health care reform. As a result of the 1994 election, it appears that President Clinton's ... -
MANAGING "MANAGED CARE": The Changing Role of The FDA In Light of A Changing Market
(1997)Change creates the necessity for more change. Advances in medical technology, and the incentives of a fee-for-service insurance system, drove up the costs of care. In response, insurers and purchasers of care began to seek ... -
Mandatory Vaccination: Why We Still Got to Get Folks to Take Their Shots
(2006)Vaccination is widely considered one of the greatest medical achievements of modern civilization. Childhood diseases that were commonplace less than a generation ago are now increasingly rare because of vaccines. In order ... -
Mandatory Vaccines: Questionable Federal Policy Informing Questionable State Laws
(2002)Among the powers retained by the states are what have become known as the police powers. The police powers include the power of the state government to promote the public welfare by restraining and regulating private ... -
MAPPING THE CONTOURS OF THE EXPERIMENTAL USE EXEMPTION: 35 U.S.C. sect. 271(E)(1)'S PAST, PRESENT, AND FUTURE
(2000)In 1984, Congress passed the Drug Price Competition and Patent Term Restoration Act (DPCPTR). This Act, which resulted from the lobbying efforts of both the pharmaceutical industry and consumer interest groups, was intended ... -
A Matter of Necessity: The Case for Mandating Health Insurance for Contraception
(2002)This paper examines the recent judicial, administrative, and federal and state legislative efforts to mandate contraceptive coverage. The paper analyzes the reasons why historically contraception has been excluded from ... -
The Meaning of Meat in Industrial Social Protest Novels;
(1996)For centuries, writers with political and social agendas have used fiction both to promote causes and to incite their readerships and legislatures into action. This article analyzes the attempts of two twentieth-century ... -
Medicaid Pharmacy Benefits Waiver Programs: A Deference Argument for Process in Informal Agency Actions
(2003)The proper level of judicial review for Section 1115 Medicaid demonstration program waiver (“waiverâ€) decisions made by the Secretary of the Department of Health and Human Services ... -
Medical Device Innovation In America: The Tensions Between Food and Drug Law and Patent Law
(2014-03-18)Medical devices are an extraordinarily large and important component of the delivery of healthcare services. This Paper examines the manner in which they are introduced into commerce and the ways in which legal privileges ... -
Memorandum to Internet Pharmacies: the Regulation and Enforcement of the Internet Pharmacy Industry
(2000)This memorandum discusses the regulation of, and enforcement regarding, the internet pharmacy industry. It concludes that the problem does not require additional regulation; existing laws are sufficient to protect against ... -
The Military’s Need For “Speed”: A Case Study On The FDA’s Regulation Of Off-Label Prescriptions
(2003)This paper is a case study in the legality and ethics of prescribing amphetamines (“go-pills”) to military aviators for fatigue management, a practice that has not been approved by the Food and Drug Administration (FDA). ... -
MISPLACED MANDATE: AN EXAMINATION OF FDA'S SILICONE BREAST IMPLANT POLICY
(1995)Why did the Food and Drug Administration (FDA) suddenly call for a forty-five day moratorium on silicone gel breast implants in 1 992 and then ban virtually all cosmetic breast implants' only months after an FDA advisory ...